Article
Natansh D. Modi, BPharm; Ahmad Y. Abuhelwa, PhD; Ross A. McKinnon, PhD
The transition from individual contributor to Medical Affairs leader with Gina Ferrari
Summary
In this episode, Gina Ferrari shares her journey into the pharmaceutical industry and her progression to an MSL manager role. She provides insights on career advancement strategies, emphasizing the value of taking on additional responsibilities and the impact of mentorship on career development. Gina discusses leadership development programs and the importance of mastering internal networking and company politics. She highlights the need for flexibility and effective communication in supporting team goals while balancing leadership responsibilities. The episode concludes with Gina's advice on documenting achievements and a look towards the future.
My guest today is Gina Ferrari, National Director MSLs and we discuss her transition from Individual Contributor to Medical Affairs Leadership.
In this episode:
- Gina’s background
- How she transitioned from an MSL to a Medical Affairs Leader
- Skills to be developed in preparation for promotion and how MSLs can position themselves the same way Gina did
- Finding mentors
- Management training programs
- Importance of internal networking
- Gina’s advice for people to help them get noticed and the steps to follow
pharmaceutical industry, MSL manager role, career advancement strategies, leadership development programs, internal networking
Related Topics
You May Also Like
Natansh D. Modi, BPharm; Ahmad Y. Abuhelwa, PhD; Ross A. McKinnon, PhD
Article
Tom Caravela
Job Search Checklist for Aspiring Medical Science Liaisons
Podcast
MSL Talk: Tom Caravela, Greg Auclair
No “D”…No Problem: Finding Success WITHOUT a Doctorate
Podcast
MSL Talk: Tom Caravela, Alicia Bullock
Change Management: How Pharma SHOULD Handle Bad News
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD